Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jun;118(3):503–512. doi: 10.1111/j.1476-5381.1996.tb15431.x

Mechanical and electrophysiological effects of 8-oxoberberine (JKL1073A) on atrial tissue.

J F Chi 1, S H Chu 1, C S Lee 1, N K Chou 1, M J Su 1
PMCID: PMC1909730  PMID: 8762071

Abstract

The effects of 8-oxoberberine (JKL1073A) on contractions and electrophysiological characteristics of atrial tissues were examined. In driven left atria of the rat JKL1073A (10-100 microM) increased twitch tension dose-dependently. In spontaneously beating right atria, JKL1073A increased twitch tension but decreased beating rate slightly. The positive inotropic and the negative chronotropic effect of 30 microM JKL1073A was not affected by prazosin (1 microM), propranolol (1 microM) and 3-isobutyl-1-methyl-xanthine (10 microM) but significantly suppressed by 4-aminopyridine (2 mM 4-AP). Current-clamp study revealed that JKL1073A prolonged rat atrial action potential duration (APD). This prolongation of APD by JKL1073A was decreased by pretreating the cells with 2 mM 4-AP. Voltage-clamp study showed that JKL1073A inhibited the integral of the transient outward current (I(to)) dose-dependently with a KD value of 3.66 +/- 0.93 microM in rat atrial myocytes. The equilibrium dissociation constant (Kd) for JKL1073A bindings to open state I(to) was 0.50 +/- 0.08 microM. The suppression of I(to) by 3 microM JKL1073A was accompanied by shortening of its inactivation time constant from 52.5 +/- 0.9 ms to 16.8 +/- 0.7 ms. V(0.5) for the steady-state inactivation curve of I(to) was shifted from -25.7 +/- 3.3 mV to -34.8 +/- 3.2 mV. In human atrial cells, similar inhibition of I(to) and prolongation of APD by JKL1073A was found. The KD value of JKL1073A for inhibition of the integral of I(to) in human atrial cells is 4.03 +/- 0.02 microM. The Kd for bindings to open state I(to) is 0.5 microM. Currents through K1 channels of rat and human atrial myocytes were not inhibited by JKL1073A at concentrations up to 10 microM. These results indicate that JKL1073A exerts a positive inotropic effect by inhibition of I(to). JKL1073A inhibit I(to) by binding to open state channels or shifting of the steady-state inactivation curve of I(to).

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahamsson C., Duker G., Lundberg C., Carlsson L. Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: a comparison with two other novel IK blocking drugs, UK-68,798 (dofetilide) and E-4031. Cardiovasc Res. 1993 May;27(5):861–867. doi: 10.1093/cvr/27.5.861. [DOI] [PubMed] [Google Scholar]
  2. Antman E. M., Beamer A. D., Cantillon C., McGowan N., Friedman P. L. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990 Mar 1;15(3):698–707. doi: 10.1016/0735-1097(90)90649-a. [DOI] [PubMed] [Google Scholar]
  3. Arena J. P., Kass R. S. Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. Mol Pharmacol. 1988 Jul;34(1):60–66. [PubMed] [Google Scholar]
  4. Barbash G. I., Hod H., Rath S., Miller H. I., Roth A., Har-Zahav Y., Modan M., Rotstein Z., Batler A., Zivelin A. Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction. Am J Cardiol. 1989 Jul 15;64(3):225–228. doi: 10.1016/0002-9149(89)90463-3. [DOI] [PubMed] [Google Scholar]
  5. Beregi J. P., Escande D., Coudray N., Mery P., Mestre M., Chemla D., Lecarpentier Y. Positive inotropic effects of RP 62719, a new pure class III antiarrhythmic agent, on guinea pig myocardium. J Pharmacol Exp Ther. 1992 Dec;263(3):1369–1376. [PubMed] [Google Scholar]
  6. Bova S., Padrini R., Goldman W. F., Berman D. M., Cargnelli G. On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling system. J Pharmacol Exp Ther. 1992 Apr;261(1):318–323. [PubMed] [Google Scholar]
  7. Campbell D. L., Qu Y., Rasmusson R. L., Strauss H. C. The calcium-independent transient outward potassium current in isolated ferret right ventricular myocytes. II. Closed state reverse use-dependent block by 4-aminopyridine. J Gen Physiol. 1993 Apr;101(4):603–626. doi: 10.1085/jgp.101.4.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Castle N. A. Bupivacaine inhibits the transient outward K+ current but not the inward rectifier in rat ventricular myocytes. J Pharmacol Exp Ther. 1990 Dec;255(3):1038–1046. [PubMed] [Google Scholar]
  9. Castle N. A. Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog. J Pharmacol Exp Ther. 1991 Apr;257(1):342–350. [PubMed] [Google Scholar]
  10. Chiou W. F., Yen M. H., Chen C. F. Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol. 1991 Oct 29;204(1):35–40. doi: 10.1016/0014-2999(91)90832-b. [DOI] [PubMed] [Google Scholar]
  11. Clark R. B., Sanchez-Chapula J., Salinas-Stefanon E., Duff H. J., Giles W. R. Quinidine-induced open channel block of K+ current in rat ventricle. Br J Pharmacol. 1995 May;115(2):335–343. doi: 10.1111/j.1476-5381.1995.tb15882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coplen S. E., Antman E. M., Berlin J. A., Hewitt P., Chalmers T. C. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990 Oct;82(4):1106–1116. doi: 10.1161/01.cir.82.4.1106. [DOI] [PubMed] [Google Scholar]
  13. Duan D., Fermini B., Nattel S. Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J Pharmacol Exp Ther. 1993 Mar;264(3):1113–1123. [PubMed] [Google Scholar]
  14. Dukes I. D., Cleemann L., Morad M. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. J Pharmacol Exp Ther. 1990 Aug;254(2):560–569. [PubMed] [Google Scholar]
  15. Dukes I. D., Morad M. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes. Am J Physiol. 1989 Nov;257(5 Pt 2):H1746–H1749. doi: 10.1152/ajpheart.1989.257.5.H1746. [DOI] [PubMed] [Google Scholar]
  16. Eisner D. A., Lederer W. J., Vaughan-Jones R. D. The control of tonic tension by membrane potential and intracellular sodium activity in the sheep cardiac Purkinje fibre. J Physiol. 1983 Feb;335:723–743. doi: 10.1113/jphysiol.1983.sp014560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Escande D., Coulombe A., Faivre J. F., Deroubaix E., Coraboeuf E. Two types of transient outward currents in adult human atrial cells. Am J Physiol. 1987 Jan;252(1 Pt 2):H142–H148. doi: 10.1152/ajpheart.1987.252.1.H142. [DOI] [PubMed] [Google Scholar]
  18. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  19. Hess P., Lansman J. B., Tsien R. W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984 Oct 11;311(5986):538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  20. Horowitz L. N., Spielman S. R., Greenspan A. M., Mintz G. S., Morganroth J., Brown R., Brady P. M., Kay H. R. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol. 1985 Dec;6(6):1402–1407. doi: 10.1016/s0735-1097(85)80232-1. [DOI] [PubMed] [Google Scholar]
  21. Josephson I. R., Sanchez-Chapula J., Brown A. M. Early outward current in rat single ventricular cells. Circ Res. 1984 Feb;54(2):157–162. doi: 10.1161/01.res.54.2.157. [DOI] [PubMed] [Google Scholar]
  22. Juul-Möller S., Edvardsson N., Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 1990 Dec;82(6):1932–1939. doi: 10.1161/01.cir.82.6.1932. [DOI] [PubMed] [Google Scholar]
  23. Kass R. S., Lederer W. J., Tsien R. W., Weingart R. Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibres. J Physiol. 1978 Aug;281:187–208. doi: 10.1113/jphysiol.1978.sp012416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kokubun S., Reuter H. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4824–4827. doi: 10.1073/pnas.81.15.4824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lathrop D. A., Nánási P. P., Schwartz A., Varró A. Ionic basis for OPC-8212-induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytes. Eur J Pharmacol. 1993 Aug 24;240(2-3):127–137. doi: 10.1016/0014-2999(93)90890-t. [DOI] [PubMed] [Google Scholar]
  26. Lathrop D. A., Varró A., Schwartz A. Rate-dependent electrophysiological effects of OPC-8212: comparison to sotalol. Eur J Pharmacol. 1989 May 30;164(3):487–496. doi: 10.1016/0014-2999(89)90256-2. [DOI] [PubMed] [Google Scholar]
  27. Lee C. O., Dagostino M. Effect of strophanthidin on intracellular Na ion activity and twitch tension of constantly driven canine cardiac Purkinje fibers. Biophys J. 1982 Dec;40(3):185–198. doi: 10.1016/S0006-3495(82)84474-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lewis R., Lakhani M., Moreland T. A., McDevitt D. G. A comparison of verapamil and digoxin in the treatment of atrial fibrillation. Eur Heart J. 1987 Feb;8(2):148–153. doi: 10.1093/oxfordjournals.eurheartj.a062242. [DOI] [PubMed] [Google Scholar]
  29. Ludan A. C. Current management of acute diarrhoeas. Use and abuse of drug therapy. Drugs. 1988;36 (Suppl 4):18–25. doi: 10.2165/00003495-198800364-00005. [DOI] [PubMed] [Google Scholar]
  30. Mason J. W., Hondeghem L. M., Katzung B. G. Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch. 1983 Jan;396(1):79–81. doi: 10.1007/BF00584702. [DOI] [PubMed] [Google Scholar]
  31. Matsuura H., Ehara T., Imoto Y. An analysis of the delayed outward current in single ventricular cells of the guinea-pig. Pflugers Arch. 1987 Dec;410(6):596–603. doi: 10.1007/BF00581319. [DOI] [PubMed] [Google Scholar]
  32. Mitra R., Morad M. A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates. Am J Physiol. 1985 Nov;249(5 Pt 2):H1056–H1060. doi: 10.1152/ajpheart.1985.249.5.H1056. [DOI] [PubMed] [Google Scholar]
  33. Nakayama T., Irisawa H. Transient outward current carried by potassium and sodium in quiescent atrioventricular node cells of rabbits. Circ Res. 1985 Jul;57(1):65–73. doi: 10.1161/01.res.57.1.65. [DOI] [PubMed] [Google Scholar]
  34. Opie L. H., Coetzee W. A. Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention. Cardiovasc Drugs Ther. 1988 Dec;2(5):623–636. doi: 10.1007/BF00054202. [DOI] [PubMed] [Google Scholar]
  35. Riccioppo Neto F. Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit. Br J Pharmacol. 1993 Feb;108(2):534–537. doi: 10.1111/j.1476-5381.1993.tb12836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sabir M., Bhide N. K. Study of some pharmacological actions of berberine. Indian J Physiol Pharmacol. 1971 Jul;15(3):111–132. [PubMed] [Google Scholar]
  37. Saman S., Coetzee W. A., Opie L. H. Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: significance for ischemic and reperfusion arrhythmias. J Mol Cell Cardiol. 1988 Feb;20(2):91–95. doi: 10.1016/s0022-2828(88)80022-1. [DOI] [PubMed] [Google Scholar]
  38. Sanguinetti M. C., Jurkiewicz N. K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990 Jul;96(1):195–215. doi: 10.1085/jgp.96.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Shaffer J. E. Inotropic and chronotropic activity of berberine on isolated guinea pig atria. J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):307–315. doi: 10.1097/00005344-198503000-00016. [DOI] [PubMed] [Google Scholar]
  40. Shibasaki T. Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. J Physiol. 1987 Jun;387:227–250. doi: 10.1113/jphysiol.1987.sp016571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shibata E. F., Drury T., Refsum H., Aldrete V., Giles W. Contributions of a transient outward current to repolarization in human atrium. Am J Physiol. 1989 Dec;257(6 Pt 2):H1773–H1781. doi: 10.1152/ajpheart.1989.257.6.H1773. [DOI] [PubMed] [Google Scholar]
  42. Steinberg J. S., Katz R. J., Bren G. B., Buff L. A., Varghese P. J. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise. J Am Coll Cardiol. 1987 Feb;9(2):405–411. doi: 10.1016/s0735-1097(87)80396-0. [DOI] [PubMed] [Google Scholar]
  43. Su M. J., Chang G. J., Kuo S. C. Mechanical and electrophysiological studies on the positive inotropic effect of 2-phenyl-4-oxo-hydroquinoline in rat cardiac tissues. Br J Pharmacol. 1993 Sep;110(1):310–316. doi: 10.1111/j.1476-5381.1993.tb13810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Su M. J., Chang Y. M., Chi J. F., Lee S. S. Thaliporphine, a positive inotropic agent with a negative chronotropic action. Eur J Pharmacol. 1994 Mar 11;254(1-2):141–150. doi: 10.1016/0014-2999(94)90381-6. [DOI] [PubMed] [Google Scholar]
  45. Su M. J., Lin S. O., Wang C. H., Tseng Y. Z., Tseng C. D. Comparison of the electrophysiological effect of amiodarone, lidocaine and quinidine on rat ventricular cells. Proc Natl Sci Counc Repub China B. 1990 Apr;14(2):105–113. [PubMed] [Google Scholar]
  46. Su M. J., Nieh Y. C., Huang H. W., Chen C. C. Dicentrine, an alpha-adrenoceptor antagonist with sodium and potassium channel blocking activities. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):42–49. doi: 10.1007/BF00178204. [DOI] [PubMed] [Google Scholar]
  47. Suttorp M. J., Kingma J. H., Jessurun E. R., Lie-A-Huen L., van Hemel N. M., Lie K. I. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol. 1990 Dec;16(7):1722–1727. doi: 10.1016/0735-1097(90)90326-k. [DOI] [PubMed] [Google Scholar]
  48. Swabb E. A., Tai Y. H., Jordan L. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol. 1981 Sep;241(3):G248–G252. doi: 10.1152/ajpgi.1981.241.3.G248. [DOI] [PubMed] [Google Scholar]
  49. Tai Y. H., Feser J. F., Marnane W. G., Desjeux J. F. Antisecretory effects of berberine in rat ileum. Am J Physiol. 1981 Sep;241(3):G253–G258. doi: 10.1152/ajpgi.1981.241.3.G253. [DOI] [PubMed] [Google Scholar]
  50. Trautwein W., Hescheler J. Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu Rev Physiol. 1990;52:257–274. doi: 10.1146/annurev.ph.52.030190.001353. [DOI] [PubMed] [Google Scholar]
  51. Wang Z., Fermini B., Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993 Aug;73(2):276–285. doi: 10.1161/01.res.73.2.276. [DOI] [PubMed] [Google Scholar]
  52. Wang Z., Fermini B., Nattel S. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther. 1995 Jan;272(1):184–196. [PubMed] [Google Scholar]
  53. Zagotta W. N., Aldrich R. W. Voltage-dependent gating of Shaker A-type potassium channels in Drosophila muscle. J Gen Physiol. 1990 Jan;95(1):29–60. doi: 10.1085/jgp.95.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES